Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jubilee Brown
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates Incorporated
Hinsdale, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- University of Massachusetts Medical School
Worcester, Massachusetts, United States
- University of Massachusetts Memorial Health Care
Worcester, Massachusetts, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Miami Valley Hospital
Dayton, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Parkland Memorial Hospital
Dallas, Texas, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- M D Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Sept 2008
- Primary completion
- 31 Jan 2013
- Completion
- 31 Jan 2013
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 36
- Registry id
- NCT00748657
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.